Cellares and GenomeFrontier to Assess Automated GF-CART01 Production
Cellares and GenomeFrontier Therapeutics have announced a collaboration to evaluate the automated manufacturing of GF-CART01,…
Newswire
Viatris’ Wakix Receives Japanese Approval for OSAS and Narcolepsy Treatment
Japan’s Ministry of Health, Labour and Welfare has granted approval for Viatris’ Wakix, a significant…
FDA Identifies New Safety Signals in Adverse Event Monitoring for Q1 2026
During the first quarter of 2026, the FDA’s Adverse Event Monitoring System (AEMS) reported new…
Novartis to pay $125M for blood-brain barrier crossing platform
Novartis has announced a significant investment of $125 million to acquire global rights to a…
GOP Advances Bill to Alter Medicare Adviser’s Analysis Favoring Health Insurers
WASHINGTON — In a notable shift in the legislative landscape, the House Ways and Means…
Loss of Brain Protein in Mice Reveals Mechanisms Behind ADHD
Recent research from the University of Fukui has identified a critical link between the loss…
Senators scrutinize Chris Klomp’s influence at HHS confirmation hearings
WASHINGTON — During recent confirmation hearings, senators from two pivotal committees closely examined the significant…
Prophylactic Phage Therapy Protects Mice Against Oral Salmonella Infection
Researchers at Virginia Tech have successfully developed a prophylactic phage therapy that protects mice from…
Cellares and GenomeFrontier Therapeutics Partner to Advance Automated Manufacturing of GF-CART01
Cellares, an integrated development and manufacturing organization (IDMO), has formed a partnership with GenomeFrontier Therapeutics,…
FDA Clarifies Policies for Compounders as National GLP-1 Supply Begins to Stabilize
The U.S. Food and Drug Administration has announced that the shortage of tirzepatide injection, a…